Average Co-Inventor Count = 7.52
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ambrx, Inc. (11 from 113 patents)
2. Elanco US Inc. (2 from 42 patents)
11 patents:
1. 11993637 - Modified FGF-21 polypeptides with non-naturally encoded amino acids
2. 11542310 - Modified bovine G-CSF polypeptides and their uses
3. 11420999 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
4. 10961291 - Modified FGF-21 polypeptides and their uses
5. 10960080 - Pegylated porcine interferon and methods of use thereof
6. 10954270 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
7. 10377805 - Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their uses
8. 9975936 - Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acids
9. 9796754 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
10. 9517273 - Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids
11. 8946148 - Modified insulin polypeptides and their uses